Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients

To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic a...

Full description

Saved in:
Bibliographic Details
Published inClinical radiology Vol. 69; no. 5; pp. 473 - 480
Main Authors Chen, B.-B., Hsu, C.-Y., Yu, C.-W., Kao, J.-H., Lee, H.-S., Liang, P.-C., Wei, S.-Y., Hwang, R.-M., Shih, T.T.-F.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2014
Subjects
Online AccessGet full text
ISSN0009-9260
1365-229X
1365-229X
DOI10.1016/j.crad.2013.12.003

Cover

Abstract To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate–severe (A2–A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal–Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses. Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05). Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function.
AbstractList To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate–severe (A2–A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal–Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses. Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05). Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function.
To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard.AIMTo evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard.Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate-severe (A2-A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal-Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses.MATERIALS AND METHODSSeventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate-severe (A2-A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal-Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses.Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤ A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05).RESULTSHepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤ A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05).Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function.CONCLUSIONGadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function.
Aim To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Materials and methods Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n  = 31), mild (A1, n  = 27), and moderate–severe (A2–A3, n  = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal–Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses. Results Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT ( p <  0.05). Conclusion Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function.
To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with histological analysis as the reference standard. Seventy-nine subjects (21 healthy subjects; 58 chronic hepatitis patients) who received gadoxetic acid-enhanced DCE-MRI were divided into three subgroups: no (A0, n = 31), mild (A1, n = 27), and moderate-severe (A2-A3, n = 21) activities. Two DCE-MRI models were measured: (1) a dual-input single-compartment model to obtain absolute arterial, portal venous, and total blood flow, arterial fraction (ART), distribution volume, and mean transit time; (2) a curve analysis method to obtain peak, slope, and AUC (area under curve). The serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels also obtained. Statistical testing included Kruskal-Wallis tests for continuous data, Pearson's correlation tests, and multiple linear regression analyses. Hepatic necro-inflammatory activity grades were significantly correlated with fibrotic stages, serum ALT level, ART and AUC. ART was helpful to predict the mild activity (≤ A1 versus >A1; Az = 0.728), whereas AUC could differentiate no activity from any activity (A0 versus >A0; Az = 0.703). Peak, slope and AUC were all associated with AST and ALT (p < 0.05). Gadoxetic acid-enhanced DCE-MRI parameters may be used to evaluate the severity of hepatic necro-inflammation and function.
Author Liang, P.-C.
Hwang, R.-M.
Kao, J.-H.
Shih, T.T.-F.
Hsu, C.-Y.
Chen, B.-B.
Wei, S.-Y.
Yu, C.-W.
Lee, H.-S.
Author_xml – sequence: 1
  givenname: B.-B.
  surname: Chen
  fullname: Chen, B.-B.
  organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 2
  givenname: C.-Y.
  surname: Hsu
  fullname: Hsu, C.-Y.
  email: joyhcy@gmail.com
  organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 3
  givenname: C.-W.
  surname: Yu
  fullname: Yu, C.-W.
  organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 4
  givenname: J.-H.
  surname: Kao
  fullname: Kao, J.-H.
  organization: Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 5
  givenname: H.-S.
  surname: Lee
  fullname: Lee, H.-S.
  organization: Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 6
  givenname: P.-C.
  surname: Liang
  fullname: Liang, P.-C.
  organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 7
  givenname: S.-Y.
  surname: Wei
  fullname: Wei, S.-Y.
  organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 8
  givenname: R.-M.
  surname: Hwang
  fullname: Hwang, R.-M.
  organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
– sequence: 9
  givenname: T.T.-F.
  surname: Shih
  fullname: Shih, T.T.-F.
  organization: Department of Medical Imaging and Radiology, National Taiwan University College of Medicine, Taipei, Taiwan, Republic of China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24556468$$D View this record in MEDLINE/PubMed
BookMark eNqFks1u1DAUhS1URKeFF2CBvGSTYDt2JqkQEqpKW6kIiR-JnWXsmxkPiTO1nYHpQ_DM2E1hUYmyurr2Ob7yd-4ROnCjA4SeU1JSQutXm1J7ZUpGaFVSVhJSPUILWtWiYKz9eoAWhJC2aFlNDtFRCJvccsafoEPGhah53SzQrwvYqmg1dqD9WFjX9WoY0snosHIGQw87FcHg3u7AY3A3-wHCCT7bqX6aZT9sXOP3Hy_xFnw3hXxkB7WybjVfrZQZf0KeobQ12Dqs1350qV_fzo424FzBxfAUPe5UH-DZXT1GX96dfT69KK4-nF-evr0qNK9ZLOiy1a3oaN1CwzqgjHBoDKtaobsWoNV02XQdWTZVDYQuuRacGsMbrrVhNAmP0cv53a0frycIUQ42aOh75WCcgqSCMiFEwpSkL-6k07cBjNz69Du_l38YJgGbBQlgCB66vxJKZA5KbmQOSuagJGUyBZVMzT2TtvGWZ_TK9g9bX89WSIB2FrwMOsHTYKwHHaUZ7cP2N_fsurcpDdV_hz2EzTh5l9BLKkMyyE95a_IO0YoQsWSZ3cm_H_jf9N-y_dia
CitedBy_id crossref_primary_10_1159_000367742
crossref_primary_10_1371_journal_pone_0197213
crossref_primary_10_1259_bjr_20201377
crossref_primary_10_3348_kjr_2024_0335
crossref_primary_10_1016_j_mri_2022_01_002
crossref_primary_10_1007_s00330_019_06179_8
crossref_primary_10_1177_0300060521997586
crossref_primary_10_1371_journal_pone_0215752
crossref_primary_10_1371_journal_pone_0193929
Cites_doi 10.1053/j.gastro.2008.02.075
10.1097/RLI.0b013e3181f9c487
10.1002/hep.1840190629
10.1002/mrm.10045
10.1136/gut.52.11.1638
10.1002/jmri.10176
10.1148/radiol.2463070077
10.2307/2532051
10.1093/clinchem/46.12.2050
10.1111/j.1572-0241.2002.06038.x
10.1002/hep.21513
10.1007/s00330-011-2249-5
10.1016/S1499-3872(12)60165-9
10.1136/gut.2006.115410
10.1148/radiol.10100995
10.1152/physrev.00027.2008
10.1371/journal.pone.0032622
10.1097/RLI.0b013e3182652fb9
10.1007/s00535-011-0513-8
10.1016/j.ejrad.2011.02.053
10.1002/jmri.23907
10.1148/radiol.2292021128
10.1007/s00330-012-2583-2
10.1148/radiol.12110337
10.1016/j.jhep.2007.07.022
10.1097/RLI.0b013e318200f67d
10.2214/ajr.176.3.1760667
10.1007/s00330-011-2316-y
10.1148/radiol.10100621
10.1053/crad.2001.0762
10.2214/AJR.10.5439
10.1053/gast.2003.50018
10.1002/jmri.23691
10.1016/0168-8278(95)80226-6
10.1007/s00330-012-2486-2
10.1002/hep.510240201
10.1097/RLI.0b013e3181a24512
10.2174/157340507780619179
10.2214/AJR.10.4387
ContentType Journal Article
Copyright 2013 The Royal College of Radiologists
The Royal College of Radiologists
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2013 The Royal College of Radiologists
– notice: The Royal College of Radiologists
– notice: Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.crad.2013.12.003
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-229X
EndPage 480
ExternalDocumentID 24556468
10_1016_j_crad_2013_12_003
S0009926013005722
1_s2_0_S0009926013005722
Genre Evaluation Studies
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29B
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEI
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OI~
OU0
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
TEORI
UHS
UV1
WH7
WUQ
X7M
Z5R
ZGI
ZXP
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
ACLOT
CITATION
~HD
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c462t-179c95f169e82fe1204e8d2395cf9ee9c178ff07836e0174c541dd484ccd21d23
IEDL.DBID .~1
ISSN 0009-9260
1365-229X
IngestDate Sat Sep 27 23:22:38 EDT 2025
Mon Jul 21 06:02:49 EDT 2025
Wed Oct 01 05:23:03 EDT 2025
Thu Apr 24 23:05:00 EDT 2025
Fri Feb 23 02:19:08 EST 2024
Sun Feb 23 10:20:30 EST 2025
Tue Aug 26 16:32:31 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-179c95f169e82fe1204e8d2395cf9ee9c178ff07836e0174c541dd484ccd21d23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
PMID 24556468
PQID 1512555455
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1512555455
pubmed_primary_24556468
crossref_primary_10_1016_j_crad_2013_12_003
crossref_citationtrail_10_1016_j_crad_2013_12_003
elsevier_sciencedirect_doi_10_1016_j_crad_2013_12_003
elsevier_clinicalkeyesjournals_1_s2_0_S0009926013005722
elsevier_clinicalkey_doi_10_1016_j_crad_2013_12_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-05-01
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: 2014-05-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical radiology
PublicationTitleAlternate Clin Radiol
PublicationYear 2014
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Hagiwara, Rusinek, Lee (bib10) 2008; 246
Van Beers, Leconte, Materne (bib27) 2001; 176
Padhani, Husband (bib36) 2001; 56
Chen, Hsu, Yu (bib23) 2012; 22
Katsube, Okada, Kumano (bib17) 2011; 46
Ghany, Kleiner, Alter (bib2) 2003; 124
Materne, Smith, Peeters (bib28) 2002; 47
Zech, Vos, Nordell (bib32) 2009; 44
Kumar, Sarin, Hissar (bib9) 2008; 134
Annet, Materne, Danse (bib29) 2003; 229
Vollmar, Menger (bib39) 2009; 89
Watanabe, Kanematsu, Goshima (bib16) 2011; 259
Sourbron, Sommer, Reiser (bib11) 2012; 263
Chen, Hsu, Yu (bib18) 2012; 47
van Kessel, Veldhuis, van den Bosch (bib12) 2012; 22
Feuerlein, Boll, Gupta (bib31) 2011; 196
Noren, Forsgren, Dahlqvist Leinhard (bib15) 2013; 23
Desmet, Gerber, Hoofnagle (bib25) 1994; 19
Asselah, Boyer, Guimont (bib1) 2003; 52
Choi, Kim, Park (bib13) 2011; 197
Okada, Ishii, Numata (bib20) 2012; 11
Ishak, Baptista, Bianchi (bib24) 1995; 22
Yankeelov, Gore (bib35) 2009; 3
Motosugi, Ichikawa, Sano (bib30) 2011; 46
Seto, Lai, Ip (bib7) 2012; 7
Bedossa, Poynard (bib26) 1996; 24
Onishi, Kim, Imai (bib14) 2012; 22
Nishie, Asayama, Ishigami (bib22) 2012; 36
Lok, McMahon (bib3) 2007; 45
Huang, Hsieh, Dai (bib4) 2007; 56
Lai, Hyatt, Nasser (bib8) 2007; 47
Chen, Hsu, Yu (bib38) 2011; 258
Dufour, Lott, Nolte (bib6) 2000; 46
Regev, Berho, Jeffers (bib5) 2002; 97
Lin (bib33) 1989; 45
Liao, Lewis (bib34) 2000; 54
Utsunomiya, Shimada, Hanaoka (bib19) 2012; 47
Nishie, Ushijima, Tajima (bib21) 2012; 81
Saito, Ledsam, Sourbron (bib40) 2013; 37
Padhani (bib37) 2002; 16
Asselah (10.1016/j.crad.2013.12.003_bib1) 2003; 52
Onishi (10.1016/j.crad.2013.12.003_bib14) 2012; 22
Van Beers (10.1016/j.crad.2013.12.003_bib27) 2001; 176
Liao (10.1016/j.crad.2013.12.003_bib34) 2000; 54
Dufour (10.1016/j.crad.2013.12.003_bib6) 2000; 46
Chen (10.1016/j.crad.2013.12.003_bib38) 2011; 258
Chen (10.1016/j.crad.2013.12.003_bib18) 2012; 47
Okada (10.1016/j.crad.2013.12.003_bib20) 2012; 11
Ishak (10.1016/j.crad.2013.12.003_bib24) 1995; 22
Regev (10.1016/j.crad.2013.12.003_bib5) 2002; 97
Kumar (10.1016/j.crad.2013.12.003_bib9) 2008; 134
Ghany (10.1016/j.crad.2013.12.003_bib2) 2003; 124
Lok (10.1016/j.crad.2013.12.003_bib3) 2007; 45
Utsunomiya (10.1016/j.crad.2013.12.003_bib19) 2012; 47
Nishie (10.1016/j.crad.2013.12.003_bib22) 2012; 36
Lai (10.1016/j.crad.2013.12.003_bib8) 2007; 47
Yankeelov (10.1016/j.crad.2013.12.003_bib35) 2009; 3
Huang (10.1016/j.crad.2013.12.003_bib4) 2007; 56
Sourbron (10.1016/j.crad.2013.12.003_bib11) 2012; 263
Noren (10.1016/j.crad.2013.12.003_bib15) 2013; 23
Padhani (10.1016/j.crad.2013.12.003_bib37) 2002; 16
Katsube (10.1016/j.crad.2013.12.003_bib17) 2011; 46
Zech (10.1016/j.crad.2013.12.003_bib32) 2009; 44
Feuerlein (10.1016/j.crad.2013.12.003_bib31) 2011; 196
Motosugi (10.1016/j.crad.2013.12.003_bib30) 2011; 46
Padhani (10.1016/j.crad.2013.12.003_bib36) 2001; 56
Choi (10.1016/j.crad.2013.12.003_bib13) 2011; 197
Lin (10.1016/j.crad.2013.12.003_bib33) 1989; 45
Chen (10.1016/j.crad.2013.12.003_bib23) 2012; 22
Watanabe (10.1016/j.crad.2013.12.003_bib16) 2011; 259
Annet (10.1016/j.crad.2013.12.003_bib29) 2003; 229
van Kessel (10.1016/j.crad.2013.12.003_bib12) 2012; 22
Saito (10.1016/j.crad.2013.12.003_bib40) 2013; 37
Seto (10.1016/j.crad.2013.12.003_bib7) 2012; 7
Hagiwara (10.1016/j.crad.2013.12.003_bib10) 2008; 246
Desmet (10.1016/j.crad.2013.12.003_bib25) 1994; 19
Bedossa (10.1016/j.crad.2013.12.003_bib26) 1996; 24
Nishie (10.1016/j.crad.2013.12.003_bib21) 2012; 81
Vollmar (10.1016/j.crad.2013.12.003_bib39) 2009; 89
Materne (10.1016/j.crad.2013.12.003_bib28) 2002; 47
References_xml – volume: 81
  start-page: 1100
  year: 2012
  end-page: 1104
  ident: bib21
  article-title: Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with technetium-99m galactosyl serum albumin scintigraphy
  publication-title: Eur J Radiol
– volume: 36
  start-page: 664
  year: 2012
  end-page: 671
  ident: bib22
  article-title: MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA
  publication-title: J Magn Reson Imaging
– volume: 56
  start-page: 736
  year: 2007
  end-page: 737
  ident: bib4
  article-title: The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies
  publication-title: Gut
– volume: 19
  start-page: 1513
  year: 1994
  end-page: 1520
  ident: bib25
  article-title: Classification of chronic hepatitis: diagnosis, grading and staging
  publication-title: Hepatology
– volume: 46
  start-page: 277
  year: 2011
  end-page: 283
  ident: bib17
  article-title: Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging
  publication-title: Invest Radiol
– volume: 259
  start-page: 142
  year: 2011
  end-page: 150
  ident: bib16
  article-title: Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging—preliminary observations
  publication-title: Radiology
– volume: 3
  start-page: 91
  year: 2009
  end-page: 107
  ident: bib35
  article-title: Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples
  publication-title: Curr Med Imaging Rev
– volume: 22
  start-page: 171
  year: 2012
  end-page: 180
  ident: bib23
  article-title: Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
  publication-title: Eur Radiol
– volume: 176
  start-page: 667
  year: 2001
  end-page: 673
  ident: bib27
  article-title: Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity
  publication-title: AJR Am J Roentgenol
– volume: 229
  start-page: 409
  year: 2003
  end-page: 414
  ident: bib29
  article-title: Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension
  publication-title: Radiology
– volume: 196
  start-page: W18
  year: 2011
  end-page: W24
  ident: bib31
  article-title: Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein
  publication-title: AJR Am J Roentgenol
– volume: 22
  start-page: 845
  year: 2012
  end-page: 854
  ident: bib14
  article-title: Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT
  publication-title: Eur Radiol
– volume: 258
  start-page: 821
  year: 2011
  end-page: 831
  ident: bib38
  article-title: Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
  publication-title: Radiology
– volume: 16
  start-page: 407
  year: 2002
  end-page: 422
  ident: bib37
  article-title: Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions
  publication-title: J Magn Reson Imaging
– volume: 47
  start-page: 470
  year: 2012
  end-page: 476
  ident: bib19
  article-title: Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve
  publication-title: J Gastroenterol
– volume: 56
  start-page: 607
  year: 2001
  end-page: 620
  ident: bib36
  article-title: Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies
  publication-title: Clin Radiol
– volume: 134
  start-page: 1376
  year: 2008
  end-page: 1384
  ident: bib9
  article-title: Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT
  publication-title: Gastroenterology
– volume: 37
  start-page: 1109
  year: 2013
  end-page: 1114
  ident: bib40
  article-title: Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol
  publication-title: J Magn Reson Imaging
– volume: 197
  start-page: 399
  year: 2011
  end-page: 405
  ident: bib13
  article-title: Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics
  publication-title: AJR Am J Roentgenol
– volume: 47
  start-page: 760
  year: 2007
  end-page: 767
  ident: bib8
  article-title: The clinical significance of persistently normal ALT in chronic hepatitis B infection
  publication-title: J Hepatol
– volume: 44
  start-page: 305
  year: 2009
  end-page: 310
  ident: bib32
  article-title: Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA
  publication-title: Invest Radiol
– volume: 263
  start-page: 874
  year: 2012
  end-page: 883
  ident: bib11
  article-title: Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging
  publication-title: Radiology
– volume: 23
  start-page: 174
  year: 2013
  end-page: 181
  ident: bib15
  article-title: Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA
  publication-title: Eur Radiol
– volume: 45
  start-page: 507
  year: 2007
  end-page: 539
  ident: bib3
  article-title: Chronic hepatitis B
  publication-title: Hepatology
– volume: 97
  start-page: 2614
  year: 2002
  end-page: 2618
  ident: bib5
  article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
  publication-title: Am J Gastroenterol
– volume: 47
  start-page: 649
  year: 2012
  end-page: 655
  ident: bib18
  article-title: Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid
  publication-title: Invest Radiol
– volume: 46
  start-page: 141
  year: 2011
  end-page: 145
  ident: bib30
  article-title: Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease
  publication-title: Invest Radiol
– volume: 124
  start-page: 97
  year: 2003
  end-page: 104
  ident: bib2
  article-title: Progression of fibrosis in chronic hepatitis C
  publication-title: Gastroenterology
– volume: 47
  start-page: 135
  year: 2002
  end-page: 142
  ident: bib28
  article-title: Assessment of hepatic perfusion parameters with dynamic MRI
  publication-title: Magn Reson Med
– volume: 54
  start-page: 23
  year: 2000
  end-page: 26
  ident: bib34
  article-title: A note on concordance correlation coefficient
  publication-title: PDA J Pharm Sci Technol
– volume: 24
  start-page: 289
  year: 1996
  end-page: 293
  ident: bib26
  article-title: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
  publication-title: Hepatology
– volume: 46
  start-page: 2050
  year: 2000
  end-page: 2068
  ident: bib6
  article-title: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring
  publication-title: Clin Chem
– volume: 7
  start-page: e32622
  year: 2012
  ident: bib7
  article-title: A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B
  publication-title: PLoS One
– volume: 45
  start-page: 255
  year: 1989
  end-page: 268
  ident: bib33
  article-title: A concordance correlation coefficient to evaluate reproducibility
  publication-title: Biometrics
– volume: 22
  start-page: 696
  year: 1995
  end-page: 699
  ident: bib24
  article-title: Histological grading and staging of chronic hepatitis
  publication-title: J Hepatol
– volume: 22
  start-page: 2153
  year: 2012
  end-page: 2160
  ident: bib12
  article-title: MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation
  publication-title: Eur Radiol
– volume: 11
  start-page: 307
  year: 2012
  end-page: 313
  ident: bib20
  article-title: Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?
  publication-title: Hepatobiliary Pancreat Dis Int
– volume: 246
  start-page: 926
  year: 2008
  end-page: 934
  ident: bib10
  article-title: Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging—initial experience
  publication-title: Radiology
– volume: 52
  start-page: 1638
  year: 2003
  end-page: 1643
  ident: bib1
  article-title: Liver fibrosis is not associated with steatosis but with necro-inflammation in French patients with chronic hepatitis C
  publication-title: Gut
– volume: 89
  start-page: 1269
  year: 2009
  end-page: 1339
  ident: bib39
  article-title: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair
  publication-title: Physiol Rev
– volume: 134
  start-page: 1376
  year: 2008
  ident: 10.1016/j.crad.2013.12.003_bib9
  article-title: Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.02.075
– volume: 46
  start-page: 141
  year: 2011
  ident: 10.1016/j.crad.2013.12.003_bib30
  article-title: Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease
  publication-title: Invest Radiol
  doi: 10.1097/RLI.0b013e3181f9c487
– volume: 19
  start-page: 1513
  year: 1994
  ident: 10.1016/j.crad.2013.12.003_bib25
  article-title: Classification of chronic hepatitis: diagnosis, grading and staging
  publication-title: Hepatology
  doi: 10.1002/hep.1840190629
– volume: 47
  start-page: 135
  year: 2002
  ident: 10.1016/j.crad.2013.12.003_bib28
  article-title: Assessment of hepatic perfusion parameters with dynamic MRI
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.10045
– volume: 52
  start-page: 1638
  year: 2003
  ident: 10.1016/j.crad.2013.12.003_bib1
  article-title: Liver fibrosis is not associated with steatosis but with necro-inflammation in French patients with chronic hepatitis C
  publication-title: Gut
  doi: 10.1136/gut.52.11.1638
– volume: 16
  start-page: 407
  year: 2002
  ident: 10.1016/j.crad.2013.12.003_bib37
  article-title: Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.10176
– volume: 54
  start-page: 23
  year: 2000
  ident: 10.1016/j.crad.2013.12.003_bib34
  article-title: A note on concordance correlation coefficient
  publication-title: PDA J Pharm Sci Technol
– volume: 246
  start-page: 926
  year: 2008
  ident: 10.1016/j.crad.2013.12.003_bib10
  article-title: Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging—initial experience
  publication-title: Radiology
  doi: 10.1148/radiol.2463070077
– volume: 45
  start-page: 255
  year: 1989
  ident: 10.1016/j.crad.2013.12.003_bib33
  article-title: A concordance correlation coefficient to evaluate reproducibility
  publication-title: Biometrics
  doi: 10.2307/2532051
– volume: 46
  start-page: 2050
  year: 2000
  ident: 10.1016/j.crad.2013.12.003_bib6
  article-title: Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring
  publication-title: Clin Chem
  doi: 10.1093/clinchem/46.12.2050
– volume: 97
  start-page: 2614
  year: 2002
  ident: 10.1016/j.crad.2013.12.003_bib5
  article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2002.06038.x
– volume: 45
  start-page: 507
  year: 2007
  ident: 10.1016/j.crad.2013.12.003_bib3
  article-title: Chronic hepatitis B
  publication-title: Hepatology
  doi: 10.1002/hep.21513
– volume: 22
  start-page: 171
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib23
  article-title: Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
  publication-title: Eur Radiol
  doi: 10.1007/s00330-011-2249-5
– volume: 11
  start-page: 307
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib20
  article-title: Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?
  publication-title: Hepatobiliary Pancreat Dis Int
  doi: 10.1016/S1499-3872(12)60165-9
– volume: 56
  start-page: 736
  year: 2007
  ident: 10.1016/j.crad.2013.12.003_bib4
  article-title: The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies
  publication-title: Gut
  doi: 10.1136/gut.2006.115410
– volume: 258
  start-page: 821
  year: 2011
  ident: 10.1016/j.crad.2013.12.003_bib38
  article-title: Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
  publication-title: Radiology
  doi: 10.1148/radiol.10100995
– volume: 89
  start-page: 1269
  year: 2009
  ident: 10.1016/j.crad.2013.12.003_bib39
  article-title: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00027.2008
– volume: 7
  start-page: e32622
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib7
  article-title: A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0032622
– volume: 47
  start-page: 649
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib18
  article-title: Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic Acid
  publication-title: Invest Radiol
  doi: 10.1097/RLI.0b013e3182652fb9
– volume: 47
  start-page: 470
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib19
  article-title: Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-011-0513-8
– volume: 81
  start-page: 1100
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib21
  article-title: Quantitative analysis of liver function using superparamagnetic iron oxide- and Gd-EOB-DTPA-enhanced MRI: comparison with technetium-99m galactosyl serum albumin scintigraphy
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2011.02.053
– volume: 37
  start-page: 1109
  year: 2013
  ident: 10.1016/j.crad.2013.12.003_bib40
  article-title: Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.23907
– volume: 229
  start-page: 409
  year: 2003
  ident: 10.1016/j.crad.2013.12.003_bib29
  article-title: Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension
  publication-title: Radiology
  doi: 10.1148/radiol.2292021128
– volume: 23
  start-page: 174
  year: 2013
  ident: 10.1016/j.crad.2013.12.003_bib15
  article-title: Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA
  publication-title: Eur Radiol
  doi: 10.1007/s00330-012-2583-2
– volume: 263
  start-page: 874
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib11
  article-title: Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging
  publication-title: Radiology
  doi: 10.1148/radiol.12110337
– volume: 47
  start-page: 760
  year: 2007
  ident: 10.1016/j.crad.2013.12.003_bib8
  article-title: The clinical significance of persistently normal ALT in chronic hepatitis B infection
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2007.07.022
– volume: 46
  start-page: 277
  year: 2011
  ident: 10.1016/j.crad.2013.12.003_bib17
  article-title: Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging
  publication-title: Invest Radiol
  doi: 10.1097/RLI.0b013e318200f67d
– volume: 176
  start-page: 667
  year: 2001
  ident: 10.1016/j.crad.2013.12.003_bib27
  article-title: Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/ajr.176.3.1760667
– volume: 22
  start-page: 845
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib14
  article-title: Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT
  publication-title: Eur Radiol
  doi: 10.1007/s00330-011-2316-y
– volume: 259
  start-page: 142
  year: 2011
  ident: 10.1016/j.crad.2013.12.003_bib16
  article-title: Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging—preliminary observations
  publication-title: Radiology
  doi: 10.1148/radiol.10100621
– volume: 56
  start-page: 607
  year: 2001
  ident: 10.1016/j.crad.2013.12.003_bib36
  article-title: Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies
  publication-title: Clin Radiol
  doi: 10.1053/crad.2001.0762
– volume: 197
  start-page: 399
  year: 2011
  ident: 10.1016/j.crad.2013.12.003_bib13
  article-title: Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.10.5439
– volume: 124
  start-page: 97
  year: 2003
  ident: 10.1016/j.crad.2013.12.003_bib2
  article-title: Progression of fibrosis in chronic hepatitis C
  publication-title: Gastroenterology
  doi: 10.1053/gast.2003.50018
– volume: 36
  start-page: 664
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib22
  article-title: MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.23691
– volume: 22
  start-page: 696
  year: 1995
  ident: 10.1016/j.crad.2013.12.003_bib24
  article-title: Histological grading and staging of chronic hepatitis
  publication-title: J Hepatol
  doi: 10.1016/0168-8278(95)80226-6
– volume: 22
  start-page: 2153
  year: 2012
  ident: 10.1016/j.crad.2013.12.003_bib12
  article-title: MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation
  publication-title: Eur Radiol
  doi: 10.1007/s00330-012-2486-2
– volume: 24
  start-page: 289
  year: 1996
  ident: 10.1016/j.crad.2013.12.003_bib26
  article-title: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
  publication-title: Hepatology
  doi: 10.1002/hep.510240201
– volume: 44
  start-page: 305
  year: 2009
  ident: 10.1016/j.crad.2013.12.003_bib32
  article-title: Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA
  publication-title: Invest Radiol
  doi: 10.1097/RLI.0b013e3181a24512
– volume: 3
  start-page: 91
  year: 2009
  ident: 10.1016/j.crad.2013.12.003_bib35
  article-title: Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples
  publication-title: Curr Med Imaging Rev
  doi: 10.2174/157340507780619179
– volume: 196
  start-page: W18
  year: 2011
  ident: 10.1016/j.crad.2013.12.003_bib31
  article-title: Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.10.4387
SSID ssj0009424
Score 2.1063757
Snippet To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with...
Aim To evaluate liver necro-inflammation and function by using gadoxetic acid-enhanced dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 473
SubjectTerms Adult
Alanine Transaminase - blood
Area Under Curve
Aspartate Aminotransferases - blood
China - epidemiology
Contrast Media
Female
Gadolinium DTPA
Hepatitis, Chronic - enzymology
Hepatitis, Chronic - immunology
Hepatitis, Chronic - pathology
Humans
Liver - blood supply
Liver - enzymology
Liver - pathology
Magnetic Resonance Imaging
Male
Middle Aged
Necrosis
Perfusion Imaging
Predictive Value of Tests
Prospective Studies
Radiology
Reference Standards
Reproducibility of Results
Sensitivity and Specificity
Severity of Illness Index
Title Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0009926013005722
https://www.clinicalkey.es/playcontent/1-s2.0-S0009926013005722
https://dx.doi.org/10.1016/j.crad.2013.12.003
https://www.ncbi.nlm.nih.gov/pubmed/24556468
https://www.proquest.com/docview/1512555455
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1365-229X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009424
  issn: 0009-9260
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect
  customDbUrl:
  eissn: 1365-229X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009424
  issn: 0009-9260
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Journals
  customDbUrl:
  eissn: 1365-229X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009424
  issn: 0009-9260
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection (subscription)
  customDbUrl:
  eissn: 1365-229X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009424
  issn: 0009-9260
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1365-229X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009424
  issn: 0009-9260
  databaseCode: AKRWK
  dateStart: 19600101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuiDfLozISNxRaO34k3Kqq1Ra0PSAq9WYZewyp2uxqsysBB34Cv5mZxFmECkXiGMejSTIPT-yZbxh7KTWQ_dlChboulAyhqEqvC1yrfRI2mBRoa2B2Yqan6u2ZPttiB2MtDKVVZt8_-PTeW-eR3fw1dxdNQzW-GN0QIhYhrltJfpjQv1CnX3__leZRK6nGbmo0OxfODDleYekJLVSU_Zbg2Djr6uL0t-CzX4SO7rDbOXrk-8MD3mVb0N5jN2f5fPw--zEFypAOvMVocF6g9qDAh-JE7tvIqZgcg8vILygdg0P77esldG_44Qbzm9PGLJ-9P-YLWKY17aXx5rJvZTTc-uTj_AtVPnIfmsiblocBX5d_7nmvmo5nsNbuATs9OvxwMC1yx4UiKCNXhFUaap2EqaGSCYTcU1BFWdY6pBqgDsJWKdHJnwE0ZRW0EjGqSoUQpcCJD9l2O2_hMeOVjdaWJoLHX1Cw0UefjEExlXsRbJ0mTIyf2oUMR05dMS7cmHd27kg8jsTjhCQQ0wl7taFZDGAc184uRwm6scwUHaPDteJaKvsnKuiybXdOuA5nuiv6N2F6Q_mbCv-T44tRvRzaNh3Y-Bbma-SE0ZjGeE_rCXs06N3mvSWOGmWqJ__J9Sm7hVdqyN18xrZXyzU8x_hq9XGnN6AddmP_-N305CejkiSS
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZhA20vpe9unyr0VkwiWQ-7txASvE12DyWB3ISqR-OSeJf1LiT9Ef3NnbHlLSVtCr1aGmRrHhqPZr4h5D2XAfVPZ8KVZSa4c1mRW5nBWW0j005Fh6GB6UxVp-LTmTzbIvtDLQymVSbb39v0zlqnJztpN3cWdY01vuDdICIWIq5rDnZ4W0iwySOyvTc5qma_sHcFF0NDNSRItTN9mpdbWgQMZXkXFRx6Z908n_7mf3bn0OEDcj85kHSvf8eHZCs0j8idaboif0x-VAGTpB1twCGcZyBAwPO-PpHaxlOsJwf_0tMLzMigofl-fRnaj_RgA_tNMTZLp58ndBGWcY3hNFpfdt2M-qGv1s-vsPiRWld7WjfU9RC79Lxbe1W3NOG1tk_I6eHByX6VpaYLmROKrxCu1JUyMlWGgsfA-K4Ihed5KV0sQygd00WMePmnAmizcLDl3otCOOc5g4lPyaiZN-E5oYX2WufKBwt_oUF7621UCjiV7_qgyzgmbNhq4xIiOTbGuDBD6tk3g-wxyB7DOOKYjsmHDc2ix-O4dXY-cNAMlaZgGw0cF7dS6T9RhTapd2uYaWGmuSGCYyI3lL9J8T9XfDeIlwH1xjsb24T5GlYCh0yCyyflmDzr5W7z3RyeKqGKF_-56ltytzqZHpvjyezoJbkHI6JP5XxFRqvlOrwGd2v15U1Sp59_MSc9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatic+necro-inflammation+and+elevated+liver+enzymes%3A+Evaluation+with+MRI+perfusion+imaging+with+gadoxetic+acid+in+chronic+hepatitis+patients&rft.jtitle=Clinical+radiology&rft.au=Chen%2C+B.-B.&rft.au=Hsu%2C+C.-Y.&rft.au=Yu%2C+C.-W.&rft.au=Kao%2C+J.-H.&rft.date=2014-05-01&rft.issn=0009-9260&rft.volume=69&rft.issue=5&rft.spage=473&rft.epage=480&rft_id=info:doi/10.1016%2Fj.crad.2013.12.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_crad_2013_12_003
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00099260%2FS0009926014X00048%2Fcov150h.gif